ALNY
Alnylam Pharmaceuticals, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Market Cap: 12.3 Billion
Primary Exchange: NASDAQ
Website: http://www.alnylam.com
Shares Outstanding: 113 Million
Float: 112 Million
Dividend: (%)
Beta: 0.693549309040505
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 603 trading days
From: 2015-06-22 To: 2017-11-09
Lowest Point:
Alnylam to Report New Clinical Results for ONPATTRO® (patisiran) at Peripheral Nerve Society (PNS) Annual Meeting and the 5th Congress of the European Academy of Neurology (EAN)
via: Business Wire at 2019-06-13 04:00:00:000
Data from Ongoing Open-Label Extension Study Highlight Durable Halting or Reversal of Neuropathy Disease Progression Relative to Baseline and Consistent Safety Profile of ONPATTRO in Patients with hATTR Amyloidosis Alnylam to Share Data Evaluating Treatment w… read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-06-10 07:37:51:000
The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...
Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-06-10 07:37:51:000
The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|